Global Over the Counter (OTC) & Diet Supplementary Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Over the Counter (OTC) & Diet Supplementary Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Over the counter (OTC) drugs are those drugs which can be picked by consumer without the prescription of doctors intended to use for diagnosis, cure, mitigation, treatment or prevention of disease.
Over the Counter (OTC) & Diet Supplementary report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Over the Counter (OTC) & Diet Supplementary market is projected to reach US$ 207730 million in 2034, increasing from US$ 135920 million in 2022, with the CAGR of 5.8% during the period of 2024 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Over the Counter (OTC) & Diet Supplementary industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Over the Counter (OTC) & Diet Supplementary key manufacturers include Bayer AG, Merck KGaA, Novartis, Johnson & Johnson, GlaxoSmithKline, Alkem Laboratories, Teva Pharmaceutical Industries, Pfizer and Sun Pharma, etc. Bayer AG, Merck KGaA, Novartis are top 3 players and held % sales share in total in 2022.
Over the Counter (OTC) & Diet Supplementary can be divided into Analgesic & Pain Relievers, Dermatological Products, Cough, Cold and Flu Products and Vitamin Supplements, etc. Analgesic & Pain Relievers is the mainstream product in the market, accounting for % sales share globally in 2022.
Over the Counter (OTC) & Diet Supplementary is widely used in various fields, such as Hospital and Clinic, etc. Hospital provides greatest supports to the Over the Counter (OTC) & Diet Supplementary industry development. In 2022, global % sales of Over the Counter (OTC) & Diet Supplementary went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Over the Counter (OTC) & Diet Supplementary market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

Bayer AG
Merck KGaA
Novartis
Johnson & Johnson
GlaxoSmithKline
Alkem Laboratories
Teva Pharmaceutical Industries
Pfizer
Sun Pharma
Allergan
Segment by Type
Analgesic & Pain Relievers
Dermatological Products
Cough, Cold and Flu Products
Vitamin Supplements
Mineral Supplements
Ophthalmic Products
Hospital
Clinic
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Over the Counter (OTC) & Diet Supplementary market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Over the Counter (OTC) & Diet Supplementary, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Over the Counter (OTC) & Diet Supplementary industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Over the Counter (OTC) & Diet Supplementary in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Over the Counter (OTC) & Diet Supplementary introduction, etc. Over the Counter (OTC) & Diet Supplementary Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Over the Counter (OTC) & Diet Supplementary market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Over the Counter (OTC) & Diet Supplementary report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Over the Counter (OTC) & Diet Supplementary market is projected to reach US$ 207730 million in 2034, increasing from US$ 135920 million in 2022, with the CAGR of 5.8% during the period of 2024 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Over the Counter (OTC) & Diet Supplementary industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Over the Counter (OTC) & Diet Supplementary key manufacturers include Bayer AG, Merck KGaA, Novartis, Johnson & Johnson, GlaxoSmithKline, Alkem Laboratories, Teva Pharmaceutical Industries, Pfizer and Sun Pharma, etc. Bayer AG, Merck KGaA, Novartis are top 3 players and held % sales share in total in 2022.
Over the Counter (OTC) & Diet Supplementary can be divided into Analgesic & Pain Relievers, Dermatological Products, Cough, Cold and Flu Products and Vitamin Supplements, etc. Analgesic & Pain Relievers is the mainstream product in the market, accounting for % sales share globally in 2022.
Over the Counter (OTC) & Diet Supplementary is widely used in various fields, such as Hospital and Clinic, etc. Hospital provides greatest supports to the Over the Counter (OTC) & Diet Supplementary industry development. In 2022, global % sales of Over the Counter (OTC) & Diet Supplementary went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Over the Counter (OTC) & Diet Supplementary market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

By Company
Bayer AG
Merck KGaA
Novartis
Johnson & Johnson
GlaxoSmithKline
Alkem Laboratories
Teva Pharmaceutical Industries
Pfizer
Sun Pharma
Allergan
Segment by Type
Analgesic & Pain Relievers
Dermatological Products
Cough, Cold and Flu Products
Vitamin Supplements
Mineral Supplements
Ophthalmic Products
Segment by Application
Hospital
Clinic
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Over the Counter (OTC) & Diet Supplementary market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Over the Counter (OTC) & Diet Supplementary, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Over the Counter (OTC) & Diet Supplementary industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Over the Counter (OTC) & Diet Supplementary in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Over the Counter (OTC) & Diet Supplementary introduction, etc. Over the Counter (OTC) & Diet Supplementary Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Over the Counter (OTC) & Diet Supplementary market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
